2014 CRO Leadership Awards Winner
Categories Won:
-
Reliability
-
Regulatory
Drug Life Cycle Stages:
Bioanalytical, Preclinical
Main Service Areas:
Bioanalytical, Clinical, Preclinical, CMC Analytical
Services & Capabilities:
Toxicology acute through carcinogenicity via standard and specialist routes, DART, safety pharmacology, genetic tox, DMPK, bioanalysis, immunoassay, cell-based assays, flow cytometry, CMC, small and large molecule, environmental risk assessment
Brian Cassmanaging director & chief operating officer“One of the world’s largest nonclinical CROs, HLS has a 60-year reputation for attracting and training the very best scientific and technical staff to consistently deliver a high-value service for our customers. We pride ourselves on a collaborative, flexible approach, making us the premium drug development partner for many of the world’s largest pharmaceutical companies, and hundreds of new and emerging companies. We’re very proud our success has been recognized with these awards.” |